COVID-19 vaccines

vaccine against SARS-CoV-2 coronavirus

thumb|upright=1.3|US Officials deliver COVID-19 vaccines to Ghana as part of the COVAX program in 2021. Ghana was the first recipient of vaccines through COVAX.

thumb|right|The general stages of seroconversion for hepatitis B, where the line of detectability indicates seropositivity In immunology, seroconversion is the development of specific antibodies in the blood serum as a result of infection or immunization, including vaccination. During infection or immunization, antigens enter the blood, and the immune system begins to produce antibodies in response. Before seroconversion, the antigen itself may or may not be detectable, but the antibody is absent. During seroconversion, the antibody is present but not yet detectable. After seroconversion, the

post vaccination adverse effects

Wikimedia list article

scientific work to develop a vaccine

misinformation regarding the SARS-CoV-2 vaccine and the resulting hesitancy towards it

ChAdOx1 is an adenoviral vector for vaccines that was developed by the Jenner Institute, University of Oxford. The vector is a chimpanzee adenovirus modified to avoid its replication.